NCT03260179View on ClinicalTrials.gov

Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

PHASE1UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

June 30, 2019

Conditions
Advanced Solid TumorAdvanced/Metastatic Colorectal Cancer
Interventions
DRUG

AL3810

Fasting，oral ，4w on or 3w on/1w off

DRUG

AL3810

Fasting，oral ，4w on or 3w on/1w off

DRUG

AL3810

Fasting，oral ，4w on or 3w on/1w off

Trial Locations (7)

200000

Fudan University Shanghai Cancer Center, Shanghai

210002

The 81st Hospital of People's Liberation Army, Nanjing

Unknown

The 307th Hospital of Chinese People's Liberation Army, Beijing

Sun Yat-sen University Cancer Center, Guangzhou

Sun Yat-sen University, Guangzhou

Jiangsu Cancer Hospital, Nanjing

Sun Yat-sen University Cancer Center, Hangzhou

Sponsors
All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Haihe Biopharma Co., Ltd.

INDUSTRY